End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.86 CNY | +0.35% | -3.26% | -15.56% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 4,503 |
Enterprise Value (EV) 1 | 3,515 |
P/E ratio | 22.4 x |
Yield | 2.13% |
Capitalization / Revenue | 2.58 x |
EV / Revenue | 2.01 x |
EV / EBITDA | 15.6 x |
EV / FCF | -241 x |
FCF Yield | -0.41% |
Price to Book | 2.38 x |
Nbr of stocks (in thousands) | 191,459 |
Reference price 2 | 23.52 |
Announcement Date | 24-04-19 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 1,279 | 1,586 | 1,847 | 1,748 |
EBITDA 1 | 162.4 | 198.3 | 229.6 | 225 |
EBIT 1 | 118.8 | 153.8 | 177.6 | 166.7 |
Operating Margin | 9.29% | 9.7% | 9.62% | 9.54% |
Earnings before Tax (EBT) 1 | 119.6 | 142.5 | 188.8 | 176.6 |
Net income 1 | 97.75 | 123.9 | 168 | 150.3 |
Net margin | 7.64% | 7.81% | 9.1% | 8.6% |
EPS 2 | 0.6800 | 0.8600 | 1.170 | 1.050 |
Free Cash Flow 1 | 29.71 | -28.58 | -0.4157 | -14.58 |
FCF margin | 2.32% | -1.8% | -0.02% | -0.83% |
FCF Conversion (EBITDA) | 18.29% | - | - | - |
FCF Conversion (Net income) | 30.39% | - | - | - |
Dividend per Share 2 | 0.5000 | 0.4000 | 0.3000 | 0.5000 |
Announcement Date | 23-11-23 | 23-11-23 | 23-11-23 | 24-04-19 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | - | - | - | - |
Net Cash position 1 | 111 | 18.8 | 3.1 | 988 |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow 1 | 29.7 | -28.6 | -0.42 | -14.6 |
ROE (net income / shareholders' equity) | 16.4% | 18.7% | 22.5% | 11.2% |
ROA (Net income/ Total Assets) | 9.82% | 11.1% | 10.5% | 6.34% |
Assets 1 | 995.7 | 1,114 | 1,604 | 2,370 |
Book Value Per Share 2 | 4.410 | 4.790 | 5.590 | 9.870 |
Cash Flow per Share 2 | 0.4900 | 0.8600 | 0.6100 | 5.610 |
Capex 1 | 72.5 | 161 | 144 | 99.7 |
Capex / Sales | 5.67% | 10.12% | 7.8% | 5.7% |
Announcement Date | 23-11-23 | 23-11-23 | 23-11-23 | 24-04-19 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-15.56% | 525M | |
-5.22% | 265B | |
-5.70% | 91.61B | |
-3.06% | 43.53B | |
+0.85% | 41.33B | |
+5.66% | 39.84B | |
+4.85% | 38.56B | |
-16.24% | 29.91B | |
-7.24% | 28.64B | |
+15.00% | 25.88B |
- Stock Market
- Equities
- 603231 Stock
- Financials Solbar Ningbo Protein Technology Co., Ltd.